Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1987 Jan;50(1):88–89. doi: 10.1136/jnnp.50.1.88

Olfactory threshold in Parkinson's disease.

N P Quinn, M N Rossor, C D Marsden
PMCID: PMC1033256  PMID: 3819760

Abstract

Olfactory threshold to differing concentrations of amyl acetate was determined in 78 subjects with idiopathic Parkinson's disease and 40 age-matched controls. Impaired olfactory threshold (previously reported by others) was confirmed in Parkinsonian subjects compared with controls. There was no significant correlation between olfactory threshold and age, sex, duration of disease, or current therapy with levodopa or anticholinergic drugs. In a sub-group of 14 levodopa-treated patients with severe "on-off" fluctuations, no change in olfactory threshold between the two states was demonstrable. Olfactory impairment in Parkinson's disease may involve mechanisms that are not influenced by pharmacologic manipulation of dopaminergic or cholinergic status.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansari K. A., Johnson A. Olfactory function in patients with Parkinson's disease. J Chronic Dis. 1975 Oct;28(9):493–497. doi: 10.1016/0021-9681(75)90058-2. [DOI] [PubMed] [Google Scholar]
  2. Esiri M. M., Wilcock G. K. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984 Jan;47(1):56–60. doi: 10.1136/jnnp.47.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ffrench-Mullen J. M., Koller K., Zaczek R., Coyle J. T., Hori N., Carpenter D. O. N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3897–3900. doi: 10.1073/pnas.82.11.3897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hillarp N. A., Fuxe K., Dahlström A. Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol Rev. 1966 Mar;18(1):727–741. [PubMed] [Google Scholar]
  5. Serby M., Corwin J., Novatt A., Conrad P., Rotrosen J. Olfaction in dementia. J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):848–849. doi: 10.1136/jnnp.48.8.848-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Simpson J., Yates C. M., Gordon A., St Clair D. M. Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's chorea. J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1138–1139. doi: 10.1136/jnnp.47.10.1138-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ward C. D., Hess W. A., Calne D. B. Olfactory impairment in Parkinson's disease. Neurology. 1983 Jul;33(7):943–946. doi: 10.1212/wnl.33.7.943. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES